Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:MSON

Misonix (MSON) Stock Price, News & Analysis

Misonix logo

About Misonix Stock (NASDAQ:MSON)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$26.54
$26.54
50-Day Range
$24.89
$26.54
52-Week Range
$11.04
$26.99
Volume
2 shs
Average Volume
60,302 shs
Market Capitalization
$462.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.

Remove Ads
Receive MSON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter.

MSON Stock News Headlines

Your Wealth is Under Attack
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
Player of the Week: Mason's Cason Carswell
See More Headlines

MSON Stock Analysis - Frequently Asked Questions

Misonix, Inc. (NASDAQ:MSON) released its quarterly earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. The medical equipment provider earned $19.69 million during the quarter. Misonix had a negative net margin of 19.55% and a negative trailing twelve-month return on equity of 10.36%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Misonix investors own include Edap Tms (EDAP), Canopy Growth (CGC), Varian Medical Systems (VAR), Fulgent Genetics (FLGT), Ampio Pharmaceuticals (AMPE), Sociedad Química y Minera de Chile (SQM) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
9/02/2021
Today
3/13/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Laboratory Apparatus & Furniture
Sub-Industry
N/A
Current Symbol
NASDAQ:MSON
Employees
254
Year Founded
1959

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-14,470,000.00
Pretax Margin
-19.37%

Debt

Sales & Book Value

Annual Sales
$74.02 million
Price / Cash Flow
N/A
Book Value
$7.77 per share
Price / Book
3.42

Miscellaneous

Free Float
11,893,000
Market Cap
$462.06 million
Optionable
Not Optionable
Beta
1.36

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:MSON) was last updated on 3/13/2025 by MarketBeat.com Staff
From Our Partners